2% lidocaine hci

Generic: 2% lidocaine hci

Labeler: hf acquisition co. llc, dba health first
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name 2% lidocaine hci
Generic Name 2% lidocaine hci
Labeler hf acquisition co. llc, dba health first
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

lidocaine hydrochloride 20 mg/mL

Manufacturer
HF Acquisition Co. LLC, DBA Health First

Identifiers & Regulatory

Product NDC 51662-1231
Product ID 51662-1231_132cd630-c24a-448d-e063-6294a90a33f8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA083158
Listing Expiration 2026-12-31
Marketing Start 2018-08-25

Pharmacologic Class

Classes
amide local anesthetic [epc] amides [cs] antiarrhythmic [epc] local anesthesia [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621231
Hyphenated Format 51662-1231

Supplemental Identifiers

RxCUI
1012068
UNII
V13007Z41A

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name 2% lidocaine hci (source: ndc)
Generic Name 2% lidocaine hci (source: ndc)
Application Number ANDA083158 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 1 SYRINGE, PLASTIC in 1 CARTON (51662-1231-1) / 5 mL in 1 SYRINGE, PLASTIC
  • 10 POUCH in 1 CASE (51662-1231-3) / 1 CARTON in 1 POUCH (51662-1231-2) / 1 SYRINGE in 1 CARTON / 5 mL in 1 SYRINGE
source: ndc

Packages (2)

51662-1231-1 1 SYRINGE, PLASTIC in 1 CARTON (51662-1231-1) / 5 mL in 1 SYRINGE, PLASTIC 51662-1231-3 10 POUCH in 1 CASE (51662-1231-3) / 1 CARTON in 1 POUCH (51662-1231-2) / 1 SYRINGE in 1 CARTON / 5 mL in 1 SYRINGE

Ingredients (1)

lidocaine hydrochloride (20 mg/mL)

Linked Drug Pages (1)

2% LIDOCAINE HCI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "132cd630-c24a-448d-e063-6294a90a33f8", "openfda": {"unii": ["V13007Z41A"], "rxcui": ["1012068"], "spl_set_id": ["74450548-62f4-b77f-e053-2991aa0ae5cf"], "manufacturer_name": ["HF Acquisition Co. LLC, DBA Health First"]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, PLASTIC in 1 CARTON (51662-1231-1)  / 5 mL in 1 SYRINGE, PLASTIC", "package_ndc": "51662-1231-1", "marketing_start_date": "20180825"}, {"sample": false, "description": "10 POUCH in 1 CASE (51662-1231-3)  / 1 CARTON in 1 POUCH (51662-1231-2)  / 1 SYRINGE in 1 CARTON / 5 mL in 1 SYRINGE", "package_ndc": "51662-1231-3", "marketing_start_date": "20230324"}], "brand_name": "2% LIDOCAINE HCI", "product_id": "51662-1231_132cd630-c24a-448d-e063-6294a90a33f8", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Local Anesthesia [PE]"], "product_ndc": "51662-1231", "generic_name": "2% LIDOCAINE HCI", "labeler_name": "HF Acquisition Co. LLC, DBA Health First", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "2% LIDOCAINE HCI", "active_ingredients": [{"name": "LIDOCAINE HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA083158", "marketing_category": "ANDA", "marketing_start_date": "20180825", "listing_expiration_date": "20261231"}